Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
ConclusionDespite an initial increase in healthcare expenditure, concomitant with reevaluation of patient care, this study showed that initiation of DPP4Is as an add-on therapy in French patients with T2D was associated with care expenditure that was in line or below predicted values within the 3 years following treatment initiation. Additional studies are required to evaluate the economic impact of the long-term treatment benefits.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Databases & Libraries | Diabetes | Endocrinology | Epidemics | Epidemiology | France Health | Health Insurance | Insurance | International Medicine & Public Health | Study